Nutrition Impact on Immunotherapy of Cancer

NCT06500234 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Nutrition Disorders
Immunotherapy
Cancer
Survival, Prosthesis

Interventions

DRUG: Megestrol Acetate and olanzapine
DRUG: Starch powder 50 mg

Sponsor

Qingdao Central Hospital